TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.46
+0.05 (1.02%)
Aug 19, 2026, 11:59 AM EDT - Market open

TriSalus Life Sciences Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, TriSalus Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $10. The average 1-year stock price forecast is 83.32% higher than the current stock price, while the lowest is $7.00 (+28.32%) and the highest is $14 (+156.65%).

Price Target: $10 (+83.32%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$10$9.50$14
Change+28.32%+83.32%+74.15%+156.65%

Analyst Ratings

The average analyst rating for TriSalus Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy544443
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total655554

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$7
BuyMaintains$7+28.32%Aug 13, 2026
Maxim Group
Maxim Group
Buy
Reiterates
$10$14
BuyReiterates$10$14+156.65%Aug 11, 2026
JonesTrading
JonesTrading
Buy
Reiterates
$11
BuyReiterates$11+101.65%Aug 10, 2026
Lake Street
Lake Street
Buy
Reiterates
$8
BuyReiterates$8+46.65%Aug 7, 2026
Northland Securities
Northland Securities
Buy
Reiterates
$13$8
BuyReiterates$13$8+46.65%Mar 23, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
52.52M
from 45.15M
Increased by 16.32%
Revenue Next Year
73.50M
from 52.52M
Increased by 39.95%
EPS This Year
-0.45
EPS Next Year
-0.25
from -0.45
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.40M12.40M18.51M29.43M45.15M52.52M
Revenue Growth
54.60%47.58%49.31%58.99%53.41%16.32%
Gross Profit
7.21M10.14M15.91M25.33M38.19M45.46M
Gross Margin
85.80%81.79%85.93%86.06%84.57%86.57%
Operating Income
-24.03M-36.44M-50.18M-36.17M-26.95M-27.29M
Net Income
-28.85M-47.19M-59.36M-30.05M-39.23M-18.98M
EPS
------0.45
Free Cash Flow
-24.49M-151.00K-48.81M-25.47M-8.76M-8.52M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High54.1M
Avg52.5M
Low49.1M

Revenue Growth

Revenue Growth202620272028
High
19.8%
Avg
16.3%
Low
8.7%

EPS Forecast

EPS202620272028
High-0.45
Avg-0.45
Low-0.45

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-